The surprising outcome of a giant primary mediastinal synovial sarcoma treated with neoadjuvant chemotherapy

被引:12
作者
Balieiro, Marcos Alexandre [1 ]
Lopes, Agnaldo Jose [2 ]
Costa, Bruno Pinheiro [3 ]
Moreira Veras, Gustavo Perisse [4 ]
Perelson, Paulo Sergio [5 ]
Nunes, Rodolfo Acatauassu [1 ]
Saito, Eduardo Haruo [1 ]
机构
[1] Univ Estado Rio De Janeiro, Div Thorac Surg, Rio De Janeiro, Brazil
[2] Univ Estado Rio De Janeiro, Div Pulm Med, Rio De Janeiro, Brazil
[3] Gen Hosp Bonsucesso, Dept Oncol, Rio De Janeiro, Brazil
[4] Univ Estado Rio De Janeiro, Div Anesthesiol, Rio De Janeiro, Brazil
[5] Oncotech Oncol, Dept Oncol, Rio De Janeiro, Brazil
关键词
Sarcoma; synovial; chemotherapy; adjuvant; mediastinum; pleural effusion; thoracic surgery; SURVIVAL;
D O I
10.3978/j.issn.2072-1439.2012.12.05
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
There are only a few cases of primary mediastinal synovial sarcoma in the literature. Normally, they do not respond well to chemotherapy. In our case, a 30-year-old patient was admitted due to thoracic pain, dyspnea, orthopnea, cough, hoarseness and weight loss over a 3-month period as well as a dramatic worsening a week before the admission. A chest radiography showed a completely white left hemithorax and contralateral mediastinal shift; in addition, a chest tomography revealed a giant heterogeneous mediastinal mass, lung atelectasia and a small pleural effusion. The patient was submitted to Chamberlain procedure (biopsy) under local anesthesia and the diagnosis of a synovial sarcoma was obtained after immunohistochemical analysis. Due to his poor general condition, he received chemotherapy first, with a dramatic response, after what, the mass that had been reduced was removed surgically. After a 5-year- follow-up period there are no signs of disease recurrence.
引用
收藏
页码:94 / 96
页数:3
相关论文
共 11 条
[1]  
Brennan M, 2005, Cancer: principles and practice of oncology, P1581
[2]   A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients [J].
Canter, Robert J. ;
Qin, Li-Xuan ;
Maki, Robert G. ;
Brennan, Murray F. ;
Ladanyi, Marc ;
Singer, Samuel .
CLINICAL CANCER RESEARCH, 2008, 14 (24) :8191-8197
[3]   Synovial sarcoma: The importance of size and location for survival [J].
Deshmukh, R ;
Mankin, HJ ;
Singer, S .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (419) :155-161
[4]  
Henninger Benjamin, 2009, Cases J, V2, P6948, DOI 10.4076/1757-1626-2-6948
[5]  
Jain A., 2009, Indian Journal of Cancer, V46, P274, DOI 10.4103/0019-509X.55547
[6]  
Jeganathan Reubendra, 2007, Ulster Med J, V76, P109
[7]   Primary mediastinal synovial sarcoma: A report of 2 cases [J].
Kaira, Kyoichi ;
Ishizuka, Tamotsu ;
Sunaga, Noriaki ;
Hashimoto, Koshi ;
Yanagitani, Noriko ;
Nonaka, Tetsuo ;
Ebara, Takeshi ;
Hisada, Takeshi ;
Mori, Masatomo .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2008, 32 (02) :238-241
[8]  
Rubin Brian P, 2007, J Natl Compr Canc Netw, V5, P411
[9]  
Singer S, 2000, Lancet Oncol, V1, P75, DOI 10.1016/S1470-2045(00)00016-4
[10]   Primary synovial sarcomas of the mediastinum - A clinicopothologic, immunohistochemical, and ultrastructural study of 15 cases [J].
Suster, S ;
Moran, CA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (05) :569-578